BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8604003)

  • 61. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
    Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Growth of human hematopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony-stimulating factor.
    Carlo-Stella C; Cazzola M; Bergamaschi G; Bernasconi P; Dezza L; Invernizzi R; Pedrazzoli P
    Leukemia; 1989 May; 3(5):363-6. PubMed ID: 2654496
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells.
    Muench MO; Schneider JG; Moore MA
    Exp Hematol; 1992 Mar; 20(3):339-49. PubMed ID: 1373685
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Modulation of neonatal myelopoiesis in newborn rats after 7 days' administration of either granulocyte-monocyte colony stimulating factor or interleukin-3.
    Cairo MS; Mauss D; Plunkett JM; Gillis S; van de Ven C
    Pediatr Res; 1991 May; 29(5):504-9. PubMed ID: 1896256
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Temporal recovery of short-term repopulating HSC subpopulations in marrow following schedule-dependent administrations of IL-1 alpha and M-CSF.
    Kovacs CJ; Evans MJ; Roberts C; Harrell J; Abernathy R; Gooya J; Johnke RM
    Exp Hematol; 1995 Aug; 23(9):1016-23. PubMed ID: 7635181
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
    Winter JN; Lazarus HM; Rademaker A; Villa M; Mangan C; Tallman M; Jahnke L; Gordon L; Newman S; Byrd K; Cooper BW; Horvath N; Crum E; Stadtmauer EA; Conklin E; Bauman A; Martin J; Goolsby C; Gerson SL; Bender J; O'Gorman M
    J Clin Oncol; 1996 Jan; 14(1):277-86. PubMed ID: 8558209
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of interleukin-4 (IL4) on myelopoiesis: studies on highly purified CD34+ hematopoietic progenitor cells.
    Snoeck HW; Lardon F; van Bockstaele DR; Peetermans ME
    Leukemia; 1993 Apr; 7(4):625-9. PubMed ID: 7681919
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of deltamethrin on the growth and differentiation of bone marrow hematopoietic stem cells.
    Queiroz ML
    Braz J Med Biol Res; 1993 May; 26(5):525-35. PubMed ID: 8257942
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
    Gazzola MV; Collins NH; Tafuri A; Keever CA
    Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965
    [TBL] [Abstract][Full Text] [Related]  

  • 71. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
    Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A
    Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mobilization of early hematopoietic progenitor cells with BB-10010: a genetically engineered variant of human macrophage inflammatory protein-1 alpha.
    Lord BI; Woolford LB; Wood LM; Czaplewski LG; McCourt M; Hunter MG; Edwards RM
    Blood; 1995 Jun; 85(12):3412-5. PubMed ID: 7540061
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Administration of recombinant human interleukin-7 alters the frequency and number of myeloid progenitor cells in the bone marrow and spleen of mice.
    Damia G; Komschlies KL; Faltynek CR; Ruscetti FW; Wiltrout RH
    Blood; 1992 Mar; 79(5):1121-9. PubMed ID: 1536940
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intravenously administered macrophage colony-stimulating factor (M-CSF) specifically acts on the spleen, resulting in the increasing and activating spleen macrophages for cytokine production in mice.
    Asakura E; Yamauchi T; Umemura A; Hanamura T; Tanabe T
    Immunopharmacology; 1997 Aug; 37(1):7-14. PubMed ID: 9285239
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anti-tumor effects of recombinant human macrophage colony-stimulating factor, alone or in combination with local irradiation, in mice inoculated with Lewis lung carcinoma cells.
    Lu L; Shen RN; Lin ZH; Aukerman SL; Ralph P; Broxmeyer HE
    Int J Cancer; 1991 Jan; 47(1):143-7. PubMed ID: 1985870
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hematopoietic stem cells in the blood after stem cell factor and interleukin-11 administration: evidence for different mechanisms of mobilization.
    Mauch P; Lamont C; Neben TY; Quinto C; Goldman SJ; Witsell A
    Blood; 1995 Dec; 86(12):4674-80. PubMed ID: 8541561
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Does macrophage-colony stimulating factor stimulate rat haematopoietic cells?
    Kudo H; Sakamoto S; Suzuki S; Mitamura T; Maemura M; Nakayama T
    Oncol Rep; 2000; 7(3):621-4. PubMed ID: 10767379
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Granulocytic and monocytic differentiation of CD34hi cells is associated with distinct changes in the expression of the PU.1-regulated molecules, CD64 and macrophage colony-stimulating factor receptor.
    Olweus J; Thompson PA; Lund-Johansen F
    Blood; 1996 Nov; 88(10):3741-54. PubMed ID: 8916938
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Administration of interleukin-6 stimulates multilineage hematopoiesis and accelerates recovery from radiation-induced hematopoietic depression.
    Patchen ML; MacVittie TJ; Williams JL; Schwartz GN; Souza LM
    Blood; 1991 Feb; 77(3):472-80. PubMed ID: 1991164
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Human macrophage colony-stimulating factor induces macrophage colonies after L-phenylalanine methylester treatment of human marrow.
    Rosenfeld CS; Evans C; Shadduck RK
    Blood; 1990 Nov; 76(9):1783-7. PubMed ID: 2224128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.